Researchers have detailed a second on-label antipsychotic treatment option that brings its own distinct mechanism and promising trial history to the table, offering clinicians and patients more personalized choices for managing agitation.

The therapy's unique approach was thoroughly studied in clinical trials, with data showing meaningful effectiveness. This expansion of treatment options represents important progress in psychiatry, giving healthcare providers greater flexibility in tailoring interventions to individual patient needs and circumstances. Read the full story →

Today's takeaway: More treatment options mean better chances of finding the right fit for each patient's mental health needs.